DOST completes VCO clinical trial

DOST completes clinical trial on VCO

Clinical trials ng DOST para sa mga posibleng gamot vs. COVID-19, patuloy; clinical trial para sa VCO bilang lunas vs. COVID-19, target matapos sa susunod na buwan

Pag-aaral ng DOST sa VCO, natapos na; Lagundi at tawa-tawa, kasama rin sa isasailalim sa clinical trial; DOH, nais baguhin ang protocol sa Avigan trial

DOST doubling efforts to fight CoVID-19; VCO clinical trials for CoVID patients ongoing

DOST: Hospital-based clinical trial ng VCO, may 42 participants na

8Resulta ng Clinical Trial sa VCO vs. COVID-19, ilalabas na sa katapusan ng Setyembre; Lagundi, nakatutulong maibsan ang sintomas ng COVID-19 ayon sa DOST

VCO, nakatutulong para mabawasan ang sintomas ng mga probable at suspected COVID-19 cases ayon sa DOST, pero ang DOH sinabing hindi gamot ang VCO para sa COVID-19

VCO, posibleng maging gamot laban sa COVID-19; COVID-19 patients na uminom ng VCO, mas mabilis na gumaling; Lagundi at Tawa-tawa, pinag-aaralan ng DOST bilang alternatibong gamot vs. COVID-19

DOST study on VCO yields promising results on mild case of COVID-19; DOST conducting study on use of lagundi against COVID-19 | via @louisaerispePTV

DOST: VCO helps reduce severity of COVID symptoms

PASADA PROBINSYA: BFAR, kinumpirmang positibo sa red tide ang ilang shellfish sa karagatan ng Visayas at Mindanao; DOST Region 2, magbibigay ng training at pondo para sa nais gawing negosyo ang paggawa ng VCO; COVID-19 vaccination sa senior citizens sa

Bisa ng VCO, lagundi at tawa-tawa vs. COVID-19, patuloy na pinag-aaralan ng DOST

Results of VCO clinical trial out end-September

Resulta ng clinical trial sa VCO bilang gamot sa COVID-19, inaasahang mailalabas sa katapusan ng buwan

VCO showing promising effect on mild CoVID-19 cases; Lagundi to undergo clinical trials as CoVID-19 supplement treatment

Clinical trials ng virgin Coconut oil, sisimulan na ng DOST

Clinical trials ng high-dose melatonin, inaprubahan na ng DOST

Clinical trial ng DOST sa Ivermectin, bilang gamot sa COVID-19, posibleng simulan ngayong buwan

DOST, tiniyak na walang masasayang na bakuna sa clinical trial ng COVID-19 vaccine mix and match

Clinical trial para sa ‘mix and match’ ng COVID-19 vaccines, target gawin sa Hunyo o Hulyo; DOST, magsasagawa rin ng hiwalay na pag-aaral para sa 'real world performance' ng COVID-19 vaccines

#Balikatan2024 officially concluded today, closing ceremony held in Camp Aguinaldo

Ship carrying aid for Gaza leaves Cyprus

Storms, twisters hit Michigan

Pasay LGU launches cleanliness, orderliness drive

PH to strictly regulate visa issuance to Chinese

PTV, Pag-IBIG fund ink memorandum of understanding

Cimatu lauds Cebu for COVID-19 response; Highway bridging Agusan del Sur, Surigao del Sur to cut down travel time; NBI-Davao takes custody of investment scheme suspect; 355 firearms destroyed in Cordillera

Trump, Biden meet for last debate before Nov. 3 election; Drone footage shows looting in Lagos

'Traslacion' 2021 canceled due to COVID-19

LTFRB guidelines on motorcycle taxis still to be issued

FDA: Sinovac submits application for clinical trials in PH

Gordon: PRC operations affected by PhilHealth debt